Tissue microarray (TMA) comprised of 233 osteosarcoma and 28 normal bone core samples (Additional file 1: Figure S1) was used to assess the expression level of CYR61 and N-cadherin (Fig. 1a). This evidence concerns the gene CDH2 and osteosarcoma.